다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Clinica chimica acta, v.429, 2014년, pp.51 - 58
Patteet, L. , Maudens, K.E. , Sabbe, B. , Morrens, M. , De Doncker, M. , Neels, H.
AI-Helper
Background: Therapeutic drug monitoring of antipsychotics is important for optimizing therapy, explaining adverse effects, non-response or poor compliance. We developed a UHPLC-MS/MS method for quantification of 16 commonly used and recently marketed antipsychotics and 8 metabolites in serum. Method...
Ther Drug Monit Patteet 34 629 2012 10.1097/FTD.0b013e3182708ec5. Therapeutic drug monitoring of common antipsychotics
Pharmacopsychiatry Baumann 37 243 2004 10.1055/s-2004-832687 The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry
Pharmacopsychiatry Hiemke 44 195 2011 10.1055/s-0031-1286287 AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Drug Test Anal Saar 4 376 2012 10.1002/dta.1337 The analysis of antipsychotic drugs in human matrices using LC-MS(/MS)
Forensic Sci Int Fisher 229 145 2013 10.1016/j.forsciint.2013.02.010 LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood
Clin Chim Acta Juenke 423C 32 2013 10.1016/j.cca.2013.04.014 Simultaneous UPLC-MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma
J Chromatogr A Ansermot 1292 160 2013 10.1016/j.chroma.2012.12.071 Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring
J Mass Spectrom Saar 45 915 2010 10.1002/jms.1783 Identification and quantification of 30 antipsychotics in blood using LC-MS/MS
J Chromatogr B Analyt Technol Biomed Life Sci Josefsson 789 151 2003 10.1016/S1570-0232(03)00207-1 Evaluation of electrospray ionisation liquid chromatography-tandem mass spectrometry for rational determination of a number of neuroleptics and their major metabolites in human body fluids and tissues
J Chromatogr B Analyt Technol Biomed Life Sci Kirchherr 843 100 2006 10.1016/j.jchromb.2006.05.031 Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC-tandem mass spectrometry: a multi-level, single-sample approach
J Mass Spectrom Kratzsch 38 283 2003 10.1002/jms.440 Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization
Anal Bioanal Chem Remane 401 1341 2011 10.1007/s00216-011-5187-9 Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs
J Chromatogr B Analyt Technol Biomed Life Sci Hasselstrom 879 123 2011 10.1016/j.jchromb.2010.11.024 Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry
J Pharm Biomed Anal Choong 50 1000 2009 10.1016/j.jpba.2009.07.007 Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS
Rapid Commun Mass Spectrom Kollroser 16 1266 2002 10.1002/rcm.718 Direct-injection high performance liquid chromatography ion trap mass spectrometry for the quantitative determination of olanzapine, clozapine and N-desmethylclozapine in human plasma
J Anal Toxicol Roman 32 147 2008 10.1093/jat/32.2.147 Quantitation of seven low-dosage antipsychotic drugs in human postmortem blood using LC-MS-MS
J Chromatogr B Analyt Technol Biomed Life Sci Zhou 802 257 2004 10.1016/j.jchromb.2003.11.037 Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry
Clin Chem Sauvage 54 1519 2008 10.1373/clinchem.2008.105478 Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis
Forensic Sci Int Peters 165 216 2007 10.1016/j.forsciint.2006.05.021 Validation of new methods
Anal Bioanal Chem Maurer 388 1315 2007 10.1007/s00216-007-1248-5 Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology
U. S. Department of Health and Human Services FDA 2001 Guidance for industry: bioanalytical method validation
European medicines agency: Comittee for medicinal products for human use 2011 Guideline on bioanalytical method validation
Anal Chem Matuszewski 75 3019 2003 10.1021/ac020361s Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS
Accred Qual Assur Wille 16 279 2011 10.1007/s00769-011-0775-0 Practical aspects concerning validation and quality control for forensic and clinical bioanalytical quantitative methods
Forensic Sci Int Fisher 229 151 2013 10.1016/j.forsciint.2013.03.021 Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum
J Chromatogr B Analyt Technol Biomed Life Sci Berna 767 163 2002 10.1016/S0378-4347(01)00548-5 Determination of olanzapine in human blood by liquid chromatography-tandem mass spectrometry
J Chromatogr B Olesen 714 309 1998 10.1016/S0378-4347(98)00205-9 Determination of olanzapine in serum by high-performance liquid chromatography using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs
Forensic Sci Int Saar 215 152 2012 10.1016/j.forsciint.2011.02.022 Assessment of the stability of 30 antipsychotic drugs in stored blood specimens
Ther Drug Monit Heller 26 459 2004 10.1097/00007691-200408000-00019 Assessment of storage and transport stability of new antidepressant and antipsychotic drugs for a nationwide TDM service
Clin Chem Annesley 49 1041 2003 10.1373/49.7.1041 Ion suppression in mass spectrometry
Anal Bioanal Chem Peters 403 2155 2012 10.1007/s00216-012-6035-2 Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology-a review
Biomed Chromatogr de Boer 26 156 2012 10.1002/bmc.1640 Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.